University of Oxford
Oxford is the oldest university in the English-speaking world and has more world-leading academics (rated 4* in the 2008 national Research Assessment Exercise) than any other UK university. Oxford also has the highest number of world-leading or internationally excellent (4* or 3*) academics in the UK.
IP Group signed its commercialisation partnership with the Department of Chemistry at Oxford in 2000, providing it with £20m towards the financing a new £60m Chemistry Research Laboratory which was opened by HM The Queen in 2004.
Oxford is one of the leading chemistry research departments in the world with around 80 academic staff carrying out international-level research and an annual research income of around £15m. The latest (2008) Research Assessment Exercise confirmed that Oxford Chemistry has the highest “power rating” (breadth and depth of science) in the UK.
The Department of Chemistry at Oxford has contributed over £80m to the University as a result of its spin-out activities. Actual realised gains from the departmental spin-outs come to more than £40m with about £20m of unrealised gains in quoted companies and a further batch of holdings in private companies.
In 2011, IP Group broadened its relationship with the University of Oxford through the acquisition of a strategic stake and alliance with Technikos LLP. Technikos is a specialist medical technology fund with a long term commercialisation agreement with the University of Oxford's Institute of Biomedical Engineering (IBME).
The IBME is a world-renowned research institute focused on bio-medical image analysis, bio-medical signal processing, bio-medical ultrasonics, drug and vaccine delivery, fluid mechanics, orthopaedics bio-medical engineering and tissue engineering and bio-processing.
IP Group and Technikos are the only two organisations to have signed exclusive commercialisation agreements with the University of Oxford to date.
www.ox.ac.uk
www.isis-innovation.com
www.chem.ox.ac.uk
www.ibme.ox.ac.uk
www.technikos.co.uk
University of Oxford Partnership Portfolio Companies
“IP Group provided seed funding for Oxford Nanopore in 2005 and we have enjoyed a productive relationship with them since that time. Particularly in the early stages when we had a smaller team, they helped us to execute fund raisings both from being networked with great investors and on the transactional support side. IPG have continued to support the company from a higher risk start-up profile to one with 100 scientists and approaching the market.”
Dr Gordon Sanghera
CEO
Oxford Nanopore Technologies Ltd